Please login to the form below

trial failures

This page shows the latest trial failures news and features for those working in and with pharma, biotech and healthcare.

Reviews start for Pfizer’s wildcard lung cancer drug dacomitinib

Regulatory reviews have started for Pfizer’s non-small cell lung cancer drug dacomitinib on both sides of the Atlantic, four years after a pair of trial failures left its future ... Dacomitinib missed its objectives in two phase III trials reported in

Latest news

Pharma sales help Bayer escape the worst from a bumpy 2017

easy”. For its pharmaceuticals business the ‘downs’included several late-stage trial failures towards the end of the year. ... Among them were a 7, 000 patient study of Xarelto in secondary stroke, a combination trial of Eylea and a drug-device
Merck BACE inhibitor adds to litany of Alzheimer's trial failures

Merck BACE inhibitor adds to litany of Alzheimer's trial failures. Interim data shows “ virtually no chance” of clinical success for verubecestat. ... The EPOCH trial enrolled patients with established mild-to-moderate Alzheimer symptoms and was due
Choose or lose

In essence, it involves sifting through thousands of 'industry episodes' such as launches, trial results, acquisitions and failures. ... The latest trial results from Amgen point out how its model is trying to create clear space from statins.
Tau protein drug fails late-stage trial

Tau protein drug fails late-stage trial. Alzheimer’ s disease therapy only showed benefit in patients with no existing treatments. ... Much of the pharma industry's efforts in Alzheimer's have been directed at the amyloid plaques seen in the brains of
Double trial disappointment for Roche

Roche's pipeline took a double hit today with disappointing trial results in both Alzheimer's disease and oncology. ... in the area considering multiple trial failures for investigational treatments in a later stage of the neurological condition.

More from news
Approximately 5 fully matching, plus 27 partially matching documents found.

Latest Intelligence

Interview: AstraZeneca's Susan Galbraith

major trial failures meaning the company was looking unlikely to fill the void created by patent expiries of key drugs.
An eye towards the biobetter in South Korea

Smaller entities such as Isu Abxis are listed companies whose stock prices and financial stability are especially vulnerable to trial failures. “ ... Some companies already have their biobetter pipelines in clinical trial stage.

More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

AstraZeneca hires Roche’s Pascal Soriot as CEO

a series of clinical trial failures leading to the departure of AZ's previous CEO Brennan in April, 2012.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Alzheimer’s disease: reviewing the immediate treatment horizon

However, the learnings from these ‘ failures’ have paved the way for the robust pipeline of treatments that could potentially be coming to market in the next five years. ... A recent article by BLH Consultant David Cooney explored the bleak

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editor – Medical Education Agency – Bucks: Salary TBC

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Medical Writer: Great salary and benefits

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Senior Programme Executive: Salary TBC

Head of Operations/ BUD, Healthcare PR, London – Excellent leade...: Excellent Package

FREELANCE Account Manager – Creative Healthcare Advertising – Lo...: SUPERB DAY RATES AVAILABLE

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Medical Writer: Great salary and bebefits

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Account Director - Global Healthcare Advertising (Digital) - Lon...: £55000 - £65000

Senior Account Manager or AD - Medical Communications: Salary TBC

Senior Account Manager – Med Comms – Kent: Salary TBC

Account Manager – Med Comms – London: Salary TBC

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Senior Account Manager / Account Director: Great salary and bebefits

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Scientific Director: Great salary and bebefits

Editorial Director – Medical Education – Oxford: Negotiable

Medical Writer - (London, Brighton or Copenhagen): Competitive

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Subscribe to our email news alerts

PMHub

Add my company

Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement: Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...